Johnson & Johnson JNJ, -0.25% stock rose 0.9% in premarket trades on Tuesday after the drug company’s profit outlook for 2023 topped analyst estimates. J&J’s fourth-quarter profit fell 25.7% t...
Tag: Pharmaceuticals
Salesforce, Abbott, Spotify, and More Stock Market Movers
This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barro...
Tesla, AT&T, Visa, Chevron, Microsoft, and More Stocks to Watch This Week
We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best Barrons.com e...
Tesla, AT&T, Visa, Chevron, Microsoft, and More Stocks for Investors to Watch This Week
We’ve detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. We’ve detected you are on Internet Explorer. For the best Barrons.com e...
The 1980s was the blueprint for the upcoming disinflation cycle and these are the stocks for it, strategists say
Stocks logged a third-straight losing session on Thursday as investors continue to deal with a mixed bag of economic data. That followed Wednesday’s session and extremely weak industrial production th...
India-Based Sun Pharma Scoops Up Concert Pharmaceuticals For $576M Plus Milestones
Sun Pharmaceutical Industries Limited, India’s top pharmaceutical company, has agreed to acquire Concert Pharmaceuticals Inc (NASDAQ: CNCE) for an upfront payment of $8.00 per share, or $576 mil...
CureVac Stock Just Got Upgraded. It’s Now a Competitor in mRNA Vaccines.
CureVac is ready to compete in the big leagues with its vaccines, according to a UBS analyst who says the soaring stock has more room to rise. UBS analyst Eliana Merle upgraded the shares (ticker: CVA...
China should set aside political issues on vaccine imports, CEO says
China needs to move past political considerations and look at importing Covid-19 jabs to end the pandemic globally, according to the chief executive of the world’s latest vaccine manufacturer. &...
Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.
Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...
Oramed’s oral insulin pill fails; stock is down 72%
Shares of Oramed Pharmaceuticals Inc. ORMP, -76.56% plunged 72% in premarket trading on Thursday, the day after the company told investors its oral insulin medication did not meet the primary or secon...
Bernie Sanders urges Moderna not to hike vaccine price
Sen. Bernie Sanders on Tuesday urged Moderna not to quadruple the price of its Covid-19 vaccine once distribution of the shots moves to the commercial market. In a letter to Moderna CEO Stephane Bance...
Sotera Health to pay $408 million to settlement allegations in Illinois
Shares of Sotera Health Co. SHC, +102.20% soared 57% in premarket trading on Tuesday after the company said it will pay $408 million to settle more than 870 million legal cases in Illinois. Sotera own...
Fed’s Powell won’t stop rate hikes until he ‘terrifies’ the wealthiest of investors, says this CIO
Investors are waking up to a whiff of positivity where stocks are concerned for Monday, after last week’s first gain in five that was prompted by weak wage growth Alongside a bleak Institute for Suppl...
Novavax’s stock rallies after the company names new CEO
Shares of Novavax Inc. NVAX, +11.25% were up about 9% in trading on Monday after the company said John Jacobs will take over as president and CEO on Jan. 23. Jacobs, the former president and CEO of Ha...
European drugmakers including AstraZeneca pony up for U.S.-listed biopharmas
European drugmakers on Monday announced a trio of deals around a billion dollars each to buy U.S.-listed biopharmas at hefty premiums. Anglo-Swedish AstraZeneca AZN, +1.42% AZN, -1.26% said it’s pay...
It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.
My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...
AbbVie cuts earnings forecast due to milestone payments
AbbVie Inc. executives lowered their outlook for the quarter and year in a filing with the Securities and Exchange Commission late Friday, which cited research and development expenses and milestone p...
UK and France say no plans currently to follow Italy with Covid tests for China arrivals
People are seen waiting at the arrivals area of terminal 5 at Heathrow International airport. Carlos Barria | Reuters LONDON — The U.K. and France said Thursday morning they currently had no plans to ...
Kala Pharmaceuticals stock up 750% in 3 days after upbeat FDA news on PCED treatment
Shares of Kala Pharmaceuticals Inc. KALA, +60.35% have rocketed higher in for three-straight sessions, toward a more-than 8-fold gain, since the biopharmaceutical company announced positive news regar...
Kala Pharmaceuticals stock rockets nearly 300% after FDA OKs IND application for PCED treatment
Shares of Kala Pharmaceuticals Inc. KALA, +219.90% quadrupled in very volatile trading Wednesday, after the biopharmaceutical company said the Food and Drug Administration accepted its investigational...
The Top 4 Dow Stock Winners of 2022
The Dow Jones Industrial Average (^INDU) began 2022 at its most robust ever. The blue chip index reached its all-time closing high at 36,799.65 points on Jan. 4, 2022. But from there, things got sha...
Stocks remain overpriced, even vs. the dot-com bubble. But you can still find good picks in these 2 sectors.
After stocks surged to their best gains in three weeks following strong consumer sentiment data, Thursday is looking less spirited with stocks in the red as we close in on the long Christmas weekend. ...
Madrigal Pharmaceuticals Stock Triples with 200% Hike on Test Results
With the FIFA season finale here’s a winner in surging as Madrigal pharmaceuticals stock price skyrocketed after its final phase study hit its goal. MDGL stock price has more than tripled as soon as M...
BioNTech upgraded to buy on high hopes for combined flu/COVID vaccine and oncology pipeline
Bank of America analysts upgraded BioNTech SE stock to buy from hold on Thursday, citing excitement about its mRNA technology and the outlook for a combined flu/COVID vaccine and oncology vaccines tha...
What investors need to know about Pfizer’s latest downgrade
Pfizer’s PFE, -0.92% early-stage pipeline, though promising, is still too premature to make up for the looming loss of billions of dollars from the company’s COVID-19 franchise, which includes the vac...